Cargando…
Programmed Cell Death Ligand 1 Pathologist Training in the Time of COVID-19: Our Experience using a Digital Solution
The COVID-19 pandemic presented numerous challenges to the continuity of programmed cell death ligand 1 (PD-L1) assay training events conducted by our organization. Under typical conditions, these training events are face-to-face affairs, where participants are trained to assay algorithms on glass s...
Autores principales: | Hayden, Dorothy, Herndon, Joseph M., Campion, James C., Feng, Janine D., Lian, Fangru, Baumann, Jessica L., Roland, Bryan K., ElGabry, Ehab A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652342/ https://www.ncbi.nlm.nih.gov/pubmed/34934522 http://dx.doi.org/10.4103/jpi.jpi_16_21 |
Ejemplares similares
-
General pathologist-helper: The new medical app about general pathology
por: Fernández-Vega, Iván
Publicado: (2015) -
A Pathologist-Annotated Dataset for Validating Artificial Intelligence: A Project Description and Pilot Study
por: Dudgeon, Sarah N., et al.
Publicado: (2021) -
Tumor Area Positivity (TAP) score of programmed death-ligand 1 (PD-L1): a novel visual estimation method for combined tumor cell and immune cell scoring
por: Liu, Chunyan, et al.
Publicado: (2023) -
Frequency and characterization of celiac ganglia diagnosed on fine-needle aspiration
por: ElGabry, Ehab A., et al.
Publicado: (2015) -
Remote Reporting During a Pandemic Using Digital Pathology Solution: Experience from a Tertiary Care Cancer Center
por: Ramaswamy, Veena, et al.
Publicado: (2021)